Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 3417976, 14 pages
http://dx.doi.org/10.1155/2016/3417976
Research Article

HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis

1Department of Infectious Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Yanjiang Road 151, Guangzhou 510120, China
2Department of Laboratory Medicine, Dongguan Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Songshan Lake Avenue 22, Dongcheng District, Dongguan 523000, China

Received 15 March 2016; Accepted 6 June 2016

Academic Editor: Shinichi Aishima

Copyright © 2016 Hao Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Jinyang Gu, Jiachang Chi, Ying Tong, Xiaoni Kong, Seogsong Jeong, Qiang Xia, Bo Zheng, Jian Wang, Lei Xia, Ning Xu, and Jianjun Zhang, “Transarterial chemoembolization: A Favorable postoperative management to improve prognosis of hepatitis B virus-associated intrahepatic cholangiocarcinoma after surgical resection,” International Journal of Biological Sciences, vol. 13, no. 10, pp. 1234–1241, 2017. View at Publisher · View at Google Scholar
  • Cheng Lou, Tong Bai, Le-Wei Bi, Ying-Tang Gao, and Zhi Du, “Negative impact of hepatitis B surface seroclearance on prognosis of hepatitis B-related primary liver cancer,” World Journal of Clinical Cases, vol. 6, no. 8, pp. 192–199, 2018. View at Publisher · View at Google Scholar
  • Fan Zhang, Yuan Liu, Kai Wang, Xu-Jin Liu, and Yu-Chen Fan, “Effects of total nocturnal sleep time and siesta on hepatocellular carcinoma risks in individuals with chronic HBV infection,” Sleep and Biological Rhythms, vol. 16, no. 1, pp. 99–105, 2018. View at Publisher · View at Google Scholar
  • Atsushi Tanaka, “Is Hepatitis B Virus–Associated Intrahepatic Cholangiocarcinoma Preventable With Antiviral Treatment?,” Clinical Gastroenterology and Hepatology, 2018. View at Publisher · View at Google Scholar
  • Do Hyun Park, Tae Jun Song, Deok-Bog Moon, Young-Joo Lee, Hyungwoo Cho, Baek-Yeol Ryoo, Kyu-Pyo Kim, Jae Ho Jeong, Han Chu Lee, Heejung Chae, Kang Mo Kim, Ju Hyun Shim, Sang Soo Lee, Shin Hwang, Gi-Won Song, Jae Hoon Lee, Changhoon Yoo, Heung-Moon Chang, Jihoon Kang, and Young-Suk Lim, “Prognostic implications of hepatitis B virus infection in intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin,” International Journal of Biological Markers, vol. 33, no. 4, pp. 432–438, 2018. View at Publisher · View at Google Scholar
  • Samira Safarikia, Vincenzo Cardinale, Lorenzo Ridola, Daniele Costantini, Lorenzo Nevi, Maria Consiglia Bragazzi, and Sabina Di Matteo, “New insights into cholangiocarcinoma: Multiple stems and related cell lineages of origin,” Annals of Gastroenterology, vol. 31, no. 1, pp. 42–55, 2018. View at Publisher · View at Google Scholar
  • Shahid A. Khan, Simona Tavolari, and Giovanni Brandi, “Cholangiocarcinoma: Epidemiology and risk factors,” Liver International, 2019. View at Publisher · View at Google Scholar
  • Peter L. Labib, George Goodchild, and Stephen P. Pereira, “Molecular Pathogenesis of Cholangiocarcinoma,” BMC Cancer, vol. 19, no. 1, 2019. View at Publisher · View at Google Scholar